Intravenous Treatment in Nursing Homes

Phase 2

Completed

• Conditions: Infections; Dehydration
• Interventions: Other: A structured training program

• Registration Number: NCT01023763
• Lead Sponsor: University of Oslo

Brief Summary

The primary objective for the project is to evaluate whether nursing home residents who require intravenous fluids and intravenous antibiotics, can be treated just as well or even better in the nursing home as in the hospital. In Vestfold, Norway, a structured training program in the intravenous treatment of dehydration and infections in nursing homes is planned. The 3IV study will evaluate if this leads to an equal or better patient trajectory and reduced hospital admittance.

Detailed Description

1. Can a structured training program in administration of intravenous fluids and antibiotics lead to a reduced number of admissions and days in hospitals among nursing home residents?

2. Can treatment with intravenous fluids or antibiotics in nursing homes provide an equally good or better patient trajectory compared to patients hospitalized for the same treatment? We will look at duration of symptoms, direct and indirect complications, and mortality rates.

3. Can treatment costs for the public health service be reduced when patients are treated with intravenous fluids and /or antibiotics in the nursing home instead of being admitted to the hospital?

4. Can treatment for dehydration and infections in the nursing home rather than in a hospital provide an equally or better satisfaction in patients, next of kin and staff?

5. How are difficult ethical issues handeld by medical staff at the nursing homes and the hospital when nursing home patients receive intravenous treatment?

Study Timeline

• Study Start: 2009-11
• Study First Submitted: 2009-12-01
• Study First Submitted QC: 2009-12-01
• Study First Posted: 2009-12-02
• Primary Completion: 2012-12
• Study Completion: 2012-12
• Status Verified: 2016-05
• Last Update Submitted: 2016-05-12
• Last Update Posted: 2016-05-13

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 330

Inclusion Criteria

• Nursing home residents in need of intravenous fluids or antibiotics

Exclusion Criteria

• Patients who needs hospitalization due to either co-morbidity or seriousness of disease

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
A training program in iv treatment	A structured training program	A structured training program in intravenous treatment in nursing homes: Each of 30 participating nursing homes sequentially received theory and practical training in intravenous treatment. In nursing homes that had completed the training program (intervention period), and had sufficient expertise and capacity, nursing home residents in need of intravenous fluids or antibiotics were treated locally; otherwise they were hospitalized.

Primary Outcome Measures

Name	Time	Method
All cause morbidity and mortality	Within 30 days after disease onset

Secondary Outcome Measures

Name	Time	Method
Patient trajectory	Primarily within 30 days after disease onset
Number of admissions and days in hospitals among nursing home residents	Primarily within 30 days after disease onset
Satisfaction in patients, next of kin and staff	Primarily within 30 days after disease onset

Trial Locations

Locations (1)

University of Oslo; 🇳🇴 Oslo, Norway